HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3- (N- prolylamine)- 2- oxo- 1- pyrrolidineacetamide

structure given in first source; RN given refers to (S-(R*,R*))-isomer; RN for cpd without isomeric designation not available 12/94; MSH Release-inhibiting hormone antagonist
Also Known As:
2-oxo-3(R)-((2(S)-pyrrolidinylcarbonyl)amino)-1-pyrrolidineacetamide; 3-(N-prolylamine)-2-oxo-1-pyrrolidineacetamide, (R-(R*,S*))-isomer; PAOPA
Networked: 10 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Mishra, Ram K: 9 articles (10/2021 - 12/2005)
2. Johnson, Rodney L: 5 articles (04/2015 - 12/2005)
3. Bhandari, Jayant: 4 articles (10/2021 - 01/2013)
4. Basu, Dipannita: 4 articles (04/2015 - 01/2011)
5. Ho, Joella: 2 articles (10/2021 - 01/2018)
6. Daya, Ritesh P: 2 articles (01/2018 - 03/2013)
7. Hui, Patricia: 2 articles (04/2015 - 01/2013)
8. Tian, Yuxin: 2 articles (04/2015 - 01/2013)
9. Daya, Ritesh: 1 article (10/2021)
10. Thomson, Sharon: 1 article (10/2021)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Neuroblastoma
3. Parkinson Disease (Parkinson's Disease)
4. Movement Disorders (Movement Disorder)
5. Tardive Dyskinesia

Related Drugs and Biologics

1. Dizocilpine Maleate (Dizocilpine)
2. Therapeutic Uses
3. glycine amide
4. Dopamine (Intropin)
5. Amphetamine (Amfetamine)
6. Synapsins (Synapsin I)
7. Proteins (Proteins, Gene)
8. Dopamine D2 Receptors (Dopamine D2 Receptor)
9. Peptidomimetics
10. MSH Release-Inhibiting Hormone (MIF-I)